Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers

Bibliography

• KING H, AUBERT RE, HERMAN WH: Global burden of diabetes 1995-2025: prevalence, numerical estimates and projections. Diabetes Care (1998) 21:1414–1431.
   PubMed Web of Science ®Google Scholar
• JAMES R, YOUNG TK, MUSTARD CA, BLANCHARD J: The health of Canadians with diabetes. Health Rep. (1997) 9:47–52.
   PubMedGoogle Scholar
• CENTRES FOR DISEASE CONTROL: The prevalence and incidence of diabetes mellitus United States, 1980-1987. MMWR (1990) 39:809–812.
   PubMedGoogle Scholar
• MELTZER S, LEITER L, DANEMAN D etal.: 1988 Clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. Can. Med. Assoc. J. (1998) 159\(Suppl. 8):S1–29.
   Google Scholar
• WETTERHALL SF, OLSN DR, DESTEFANO S et al.: Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care (1992) 15:960–967.
   PubMed Web of Science ®Google Scholar
• CLARK CM JR.: The burden of chronic hyperglycemia. Diabetes Care (1998) 21\(Suppl. 3):C32–34.
   Google Scholar
• THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl. J. Med. (1993) 329:977–986.
   PubMed Web of Science ®Google Scholar
• UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional therapy and the risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet (1998) 352:837–853.
   PubMed Web of Science ®Google Scholar
• UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP: Effect of intensive blood - glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet (1998) 352:854–865.
   PubMed Web of Science ®Google Scholar
• REIBER GE, LIPSKY BA, GIBBONS GW: The burden of diabetic foot ulcers. Am. j. Surg. (1998) 176(Suppl. 2A):55-10S.
   Google Scholar
• •This paper summarises the burden of diabetic foot ulcerations.
   Google Scholar
• HUSE DM, OSTER G, KILLEN AR, LACEY MJ, COLDITZ GA: The economic cost of non-insulin dependent diabetes mellitus. JAMA (1989) 262:2708–2713.
   PubMed Web of Science ®Google Scholar
• •This paper brings forth the cost of care for persons with non-insulin dependent diabetes mellitus.
   Google Scholar
• LAUGHLIN RT, CALHOUN JH, MADER JT: The diabetic foot. j. Am. Acad. Draw. Surg (1995) 3:218–225.
   Google Scholar
• NWOMEH BC, YAGER DR, COHEN IK: Physiology of the chronic wound. Clio.
   Google Scholar
• •• Plast. Surg. (1998) 25:341–356.
   Google Scholar
• ALLMAN RIVI: Pressure ulcer prevalence, incidence, risk factors and impact. Clin. Ceriatr. Med (1997) 13:421–436.
   PubMed Web of Science ®Google Scholar
• NELZEN 0, BERGQVIST D, LINDHAGEN A, HALLBOOK T: Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. Epidemiol Community Health (1991) 45:184–187.
   Google Scholar
• PECORARO RE, REIBER GE, BURGESS EM: Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care (1990) 13:513–521.
   PubMed Web of Science ®Google Scholar
• STEED DL, DIABETIC ULCER STUDY GROUP: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J. Vasc. Surg. (1995) 21:71–78.
   PubMed Web of Science ®Google Scholar
• ••Important clinical trial. This study reportsthe benefits of becaplermin for the treatment of ulcerations in the lower extremities of diabetics.
   Google Scholar
• BOULTON AJ: Lawrence Lecture. The diabetic foot: neuropathic in aetiology? Diabet. Med. (1990) 7:852–858.
   Google Scholar
• WAGNER FW JR.: The dysvascular foot: A system for diagnosis and treatment. Foot Ankle. (1981) 2:64–122.
   PubMedGoogle Scholar
• BRODSKY JW: Outpatient diagnosis and care of the diabetic foot. Instr. Course Lect. (1993) 42:121–139.
   PubMedGoogle Scholar
• MILLER OF 3rd: Chronic foot wounds in diabetics and total contact casting. Clin. Dermatol (1994) 12:39–45.
   PubMed Web of Science ®Google Scholar
• STEED DL: Foundations of good ulcer care. Am. J. Surg. (1998) 176 (2A Suppl):20S–25S.
   Google Scholar
• AMERICAN DIABETES ASSOCIATION: Diabetes 1996: Vital statistics. Cowie CC, Eberhardt MS ( Eds.), American Diabetes Association, Alexandria VA, (1996).
   Google Scholar
• ROBSON MC: Wound Infection. A failureof wound healing caused by an imbalance of bacteria. Surg. Clin. North Am. (1997) 77:637–650.
   Google Scholar
• BENNETT NT, SCHULTZ GS: Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am. Surg. (1993) 166:74–81.
   Google Scholar
• MARTIN P: Wound healing-aiming for perfect skin regeneration. Science (1997) 276:75–81.
   PubMed Web of Science ®Google Scholar
• STADELMANN WK, DIGENIS AG, TOBIN GR: Physiology and healing dynamics of chronic cutaneous wounds. Am. Surg. (1998) 176 (2A Suppl.):265–385.
   Google Scholar
• ••A good summary outlining the salientfeatures of wound healing.
   Google Scholar
• SINGER AJ, CLARK RA: Cutaneous wound healing. N Engl. I Med (1999) 341:738–746.
   PubMed Web of Science ®Google Scholar
• ••An excellent review article of woundhealing.
   Google Scholar
• EMBIL JM. Becaplermin (Regranex® gel 0.01%): recombinant platelet-derived growth factor (rh-PDGF-BB) for healing diabetic foot ulcers. Today s Therapeutic Trends (2000) 18:131–148.
   Google Scholar
• ••An extensive review of becaplermin for thehealing of diabetic foot ulcers.
   Google Scholar
• BUCALO B, EAGLSTEIN WH, FALANGA V: The effect of chronic wound fluid on cell proliferation in vitro. j Invest. Dermatol (1989) 92:408–412.
   Web of Science ®Google Scholar
• KATZ MH, ALVAREZ AF, KIRSNER RS, EAGLSTEIN WH, FALANGA V: Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. I Am. Acad. Dermatol. (1991) 25(6 Pt 1):1054–1058.
   Google Scholar
• COOPER DM, YU EZ, HENNESSEY P, KO F, ROBSON MC: Determination of endogenous cytokines in chronic wounds. Ann. Surg. (1994) 219:688–691.
   PubMed Web of Science ®Google Scholar
• ROBSON MC: The role of growth factors in the healing of chronic wounds. Wound Repair Regen (1997) 5:12–17.
   PubMedGoogle Scholar
• GREENHALGH DG: The role of growth factors in wound healing. I Trauma (1996) 41:159–167.
   PubMed Web of Science ®Google Scholar
• ROSS R: Platelet-derived growth factor. Lancet (1989) 1:1179–1182.
   PubMed Web of Science ®Google Scholar
• HART CE, FORSTROM JW, KELLY JD et al.: Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 240:1529–1531.
   PubMed Web of Science ®Google Scholar
• MEYER-INGOLD W, EICHNER W: Platelet-derived growth factor. Cell Biol. Int. (1995) 19:389–398.
   PubMed Web of Science ®Google Scholar
• PIERCE GF, MUSTOE TA, SENIOR RM et al.: In vitro incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. I Esp. Med. (1988) 167:974–987.
   Google Scholar
• LEGRAND EK: Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. AM J Surg (1998) 176(Suppl. 2A):48S–54S.
   Google Scholar
• ENGRAV LH, RICHEY KJ, KAO CC, MURRAY MJ: Topical growth factors in wound contraction in the rat Part II. Platelet-derived growth factor and wound contraction in normal and steroid-impaired rats. Ann. Plast. Surg. (1989) 23:245–248.
   Google Scholar
• MUSTOE TA, PURDY J, GRAMATES P,DEUEL TF, THOMAS ON A, PIERCE GF: Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB. Am. J Surg. (1989) 158:345–350.
   PubMed Web of Science ®Google Scholar
• PIERCE GF, MUSTOE TA, LINGELBACH J etal.: Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. I Cell Biol. (1989) 109:429–440.
   Google Scholar
• KHOURI RK, KOUDSI B, DEUNE EG et al.: Tissue generation with growth factors. Surgery (1993) 114:374–380.
   PubMed Web of Science ®Google Scholar
• LE GRAND EK, NICIPORCIUKS MC, DONETZ AP et al: Comparison of pig and guinea pig full and partial thickness skin excision wound models for evaluating the effects of rhPDGF-BB. Wounds (1995) 7:78–89.
   Google Scholar
• MUSTOE TA, PIERCE GF, MORISHIMA C, DEUEL TF: Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. I Clin. Invest. (1991) 87:694–703.
   PubMed Web of Science ®Google Scholar
• WIEMAN TJ, SMIELL JM, SU Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A Phase III randomized placebo-controlled double-blind study. Diabetes Care (1998) 21:822–827.
   PubMed Web of Science ®Google Scholar
• ••Important study highlighting theimportance of becaplermin for the management of diabetic foot ulcerations.
   Google Scholar
• D'HEMERCOURT PA, SMIELL JM, KARIM MR: Effect of sodium carboxymethylcellulose aqueous-based gel vs. becaplerin gel in patients with non-healing lower extremity diabetic ulcers. Wounds (1998) 10:69–75.
   Google Scholar
• ••This study summarises the role ofbecaplermin for the healing of diabetic foot ulcerations.
   Google Scholar
• WIEMAN TJ: Clinical efficacy of becaplermin (rh PDGF-BB) gel. Am. I Surg. (1998) 176(Suppl. 2A):745–795.
   Google Scholar
• ••The role of becaplermin in the healing ofdiabetic foot ulcerations is reviewed in this publication.
   Google Scholar
• SMIELL JM, WIEMAN TJ, STEED DL, PERRY BH, SAMPSON AR, SCHWAB BH: Efficacy and safety of becaplermin
   Google Scholar
• EMBIL JM, PAPP K, SIBBALD G et al.: Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. Wound Repair Regen. (2000) 8:162–168.
   PubMed Web of Science ®Google Scholar
• ••This study describes the results of an open label evaluation of becaplermin, using standardised weight displacement techniques.
   Google Scholar
• MARGOLIS DJ, KANTOR J, BERLIN JA: Healing of diabetic neuropathic foot ulcers receiving standard treatment in meta-analysis. Diabetes Care (1999) 22:692–695.
   PubMed Web of Science ®Google Scholar
• ROSE G, DUERKSEN F, BLANCHARD J etComplications of the lowerextremities in persons with diabetes presenting to multi-disciplinary foot clinic. BSc. (Med.) Oral Presentations: Program Proceedings. University of Manitoba, Winnipeg, Manitoba, Canada. (1999):141–147.
   Google Scholar
• KANTOR J, MARGOLIS DJ: Treatmentoptions for diabetic neuropathic foot ulcers: A cost-effectiveness analysis. Dermatol Surg. (2001) 27:347–351.
   PubMed Web of Science ®Google Scholar